Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
Study NCT ID:
NCT01088620
Status:
SUSPENDED
Last Update Posted:
2013-03-14
First Post:
2010-03-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
Sponsor:
WiSP Wissenschaftlicher Service Pharma GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-01
Completion Date Type:
ESTIMATED
First Submit Date:
2010-03-16
First Submit QC Date:
None
Study First Post Date:
2010-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-13
Last Update Post Date:
2013-03-14
Last Update Post Date Type:
ESTIMATED